Pathogen Reduced Cryoprecipitated Fibrinogen Complex

prepared from the INTERCEPT® Blood System for Cryoprecipitation

INTERCEPT Fibrinogen Complex

Be ready.
When minutes matterTM

with thawed INTERCEPT® Fibrinogen Complex (IFC),
the only immediate source* of fibrinogen with a 5-day post-thaw shelf life.

INTERCEPT® FIBRINOGEN COMPLEX (IFC)

is approved specifically for the treatment and control of bleeding, including massive hemorrhage,
associated with fibrinogen deficiency.1

The IFC Advantage

5-Day Post-Thaw Shelf Life

Transfuse
Immediately*

Protect
Patients†

Minimize
Wastage

Control Bleeding

† Broad spectrum transfusion transmitted infection risk reduction.

Be ready. When minutes matterTM

Transfuse Immediately*
When controlling hemorrhage, faster is better.

DELAY INCREASES MORTALITY2

 Every minute of delay between the activation of a massive transfusion protocol (MTP) and the arrival of the first blood products, results in a 5% increase in the odds of mortality.2

LEARN MORE

5-day post-thaw shelf life allows IFC to be thawed in advance and available for immediate, empirical use.

Protect Patients
IFC provides broad spectrum transfusion transmitted infection (TTI) risk reduction by
inactivating viruses, bacteria, protozoans, and leukocytes.**

IFC is produced from plasma pathogen reduced by the
INTERCEPT® Blood System for Plasma.3

Minimize Wastage
Transfusion-ready*, room temperature IFC minimizes wait times and wastage rates,
addressing common inventory challenges.

Cryoprecipitated AHF Inventory Challenges

Long
Wait Times

15 min – 2.8 hours4,5

Stored frozen and typically thawed in round 2 or 3 of MTP6

Short
Shelf Life

4 – 6 hours7

Post thaw due in part
to infectious risk

High
Wastage Rates

7 – 33%6

Thawed cryo AHF
is wasted

Control Bleeding
IFC is an enriched source of fibrinogen, factor XIII, von Willebrand factor, and other
constituents, restoring clot strength and hemostasis.

Fibrinogen, factor XIII, and von
Willebrand factor add the clotting
strength needed to achieve stable clot
formation and restore hemostasis.8

LEARN MORE

The ready-to-use* pathogen reduced, fibrinogen enriched IFC treats and controls bleeding,
including massive hemorrhage, associated with fibrinogen deficiency.1

The IFC Advantage

5-Day Post-Thaw Shelf Life

Transfuse
Immediately*

Protect
Patients†

Minimize
Wastage

Control Bleeding

† Broad spectrum transfusion transmitted infection risk reduction.

Be ready. When minutes matterTM